Macquarie Group’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.88M | Sell |
|
|||||
|
2025
Q2 | $2.49M | Hold |
|
|||||
|
2025
Q1 | $2.15M | Buy |
|
|||||
|
2024
Q4 | $1.18M | Sell |
|
|||||
|
2024
Q3 | $1.32M | Hold |
|
|||||
|
2024
Q2 | $1.23M | Buy |
|
|||||
|
2024
Q1 | $1.39M | Hold |
|
|||||
|
2023
Q4 | $1.28M | Buy |
|
|||||
|
2023
Q3 | $991K | Buy |
|
|||||
|
2023
Q2 | $560K | Buy |
|
|||||
|
2023
Q1 | $332K | Hold |
|
|||||
|
2022
Q4 | $364K | Buy |
|
|||||
|
2022
Q3 | $285K | Buy |
|
|||||
|
2022
Q2 | $195K | Hold |
|
|||||
|
2022
Q1 | $180 | Buy |
|
|||||
|
2021
Q4 | $107K | Sell |
|
|||||
|
2021
Q3 | $184K | Hold |
|
|||||
|
2021
Q2 | $209K | Buy |
|
|||||
|
2021
Q1 | $216K | Buy |
|
|||||
|
2020
Q4 | $100K | Buy |
|